ICPT Stock Summary

• ICPT's price/sales ratio is 11.36; that's higher than the P/S ratio of 90.66% of US stocks.
• ICPT's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 93.23% of US stocks.
• Revenue growth over the past 12 months for Intercept Pharmaceuticals Inc comes in at 38%, a number that bests 86.38% of the US stocks we're tracking.
• If you're looking for stocks that are quantitatively similar to Intercept Pharmaceuticals Inc, a group of peers worth examining would be CERS, NSTG, PLUG, PACB, and VUZI.
• ICPT's SEC filings can be seen here. And to visit Intercept Pharmaceuticals Inc's official web site, go to www.interceptpharma.com.